Abbott Norvir Pricing Needs Investigation By FTC, Senators Say

Senators Hollings, McCain and Schumer urge FTC to investigate the possible anticompetitive effects that Norvir's price increase may have on other protease inhibitors. The request comes the week before NIH will hold a public meeting to consider granting compulsory licensing of Norvir's patents.